Advanced search
Publication Cover
Clinical Toxicology Volume 54, 2016 - Issue 4
Submit an article Journal homepage
3,823
Views
55
CrossRef citations to date
0
Altmetric
Abstracts

36th International Congress of the European Association of Poisons Centres and Clinical Toxicologists (EAPCCT) 24-27 May, 2016, Madrid, Spain

Pages 344-519 | Published online: 21 Apr 2016

References

Reference

Reference

  • Hermanns-Clausen M, Desel H, Färber E, et al. MAGAM II: Prospective observational multicentre poisons centre study on eye exposures caused by cleaning products. Clin Toxicol (Phila). 2015;53:315–316.

Reference

  • Whitney RE, Baum CR, Aronson PL. Diffuse corneal abrasion after ocular exposure to laundry detergent pod. Pediatr Emerg Care. 2015;31:127–128.

Reference

  • Celentano A, Sesana F, Settimi L, et al. Accidental exposures to liquid detergent capsules. Clin Toxicol (Phila). 2012;50:353.

References

References

  • Sussan S, Dagan A, Blotnik S, et al. The structural requirements for the design of antiepileptic-glycine derivatives. Epilepsy Res. 1999;34:207–220.
  • O’Brien EM, Dosterrt P, Pevarello P, et al. Interactions of some analogues of the anticonvulsant milacemide with monoamine oxidase. Biochem Pharmacol. 1994;48:905–914.
  • Papa P, Rocchi L, Rolandi L, Valli A, et al. [Research and identification of new psychoactive substances in cases of suspected intoxication in Italy.] [Article in Italian] Italian Journal of Addiction. 2014;4:50–56.

Reference

References

  • Dean BV, Stellpflug SJ, Burnett AM, et al. 2C or not 2C: phenethylamine designer drug review. J Med Toxicol. 2013;9:172–178.
  • Shulgin A, Shulgin A. PIHKAL: a chemical love story. Berkeley, USA: Transform Press, 1991.
  • Srisuma S, Bronstein AC, Hoyte CO. NBOMe and 2C substitute phenylethylamine exposures reported to the National Poison Data System. Clin Toxicol (Phila). 2015;53:624–628.

Reference

  • Beck O, Rausberg L, Al-Saffar Y, et al. Detectability of new psychoactive substances, 'legal highs', in CEDIA, EMIT, and KIMS immunochemical screening assays for drugs of abuse. Drug Test Anal. 2014;6:492–499.

References

References

Reference

References

Reference

  • Smolinske SC, Spoerke DG, Spiller SK, et al. Cigarette and nicotine chewing gum toxicity in children. Hum Toxicol. 1988; 7:27–31.

Reference

Reference

  • Rauber-Lüthy C, Kupferschmidt H. Household chemicals: management of intoxication and antidotes. EXS. 2010;100:339–363.

References

  • Okonek S, Reinecke HJ, Krienke EG, et al. [Poisoning by hypochlorite-containing disinfectants. A retrospective analysis of 594 cases of poisoning.] [Article in German] Dtsch Med Wochenschr. 1984; 109:1874–1877.
  • Siodlak MZ, Gleeson MJ, Wengraf CL. Accidental ingestion of sterilising tablets by children. Br Med J (Clin Res Ed). 1985;290:1707–8.

References

  • Cassidy N, Tracey JA. Morbidity and mortality following inadvertent poisoning with decanted chemicals. Ir Med J. 2005;98:175–178.
  • Geller RJ, Kezirian R, Bangar P, et al. Epidemiology of accidental poisoning caused by storage of non-food substances in food containers and unmarked bottles/containers. Clin Toxicol (Phila). 2009; 47:705.

References

  • Martínez R, Mencías E. Productos de limpieza domésticos. In: Mencías Rodríguez E, Mayero Franco LM, eds. Manual de Toxicología básica. Madrid, Spain: Ed. Díaz de Santos; 2000:452–4.
  • Real Decreto 770/1999, de 7 de mayo, por el que se aprueba la Reglamentación técnico-sanitaria para la elaboración, circulación y comercio de detergentes y limpiadores. Boletín Oficial del Estado, 18 de mayo de 1999, núm. 118, de 18 de mayo de 1999, 18545–51.
  • Commission Regulation (EU) No 453/2010 of 20 May 2010 amending Regulation (EC) No 1907/2006 of the European Parliament and of the Council on the Registration, Evaluation, Authorisation and Restriction of Chemicals (REACH). OJEU 2010;L133/1--43.

References

References

  • Rodgers Jr GC, Tenenbein M. The role of aversive bittering agentsin the prevention of pediatric poisonings. Pediatrics. 1994;93:68.
  • SCCS/1359/10 Scientific Committee on Consumer Safety. Opinion on the potential health risks posed by chemical consumer products resembling food and/or having child-appealing properties. 8.3 pages 21–22.

References

  • Mehrpour O, Sezavar SV. Diagnostic imaging in body packers. Mayo Clin Proc. 2012;87:e53–e54.
  • Karrari P, Mehrpour O, Balali-Mood M. Iranian Crystal: a misunderstanding of the crystal-meth. J Res Med Sci. 2012;17:203–204.
  • Zavar A, Afshari R, Alidoust M, et al. Curriculum development in regard to illicit drug abuse. FMEJ. 2012;2:31–36.
  • Mehrpour O, Karrari P, Afshari R. Recreational use and overdose of ingested processed cannabis (Majoon Birjandi) in the eastern Iran. Hum Exp Toxicol. 2012;31:1188–1189.

Reference

Reference

Reference

Reference

Reference

  • Hollander JE, Todd KH, Green G, et al. Chest pain associated with cocaine: an assessment of prevalence in suburban and urban emergency departments. Ann Emerg Med. 1995;26:671–676.

Reference

  • Chaoui H, Rhalem N, Semlali I, et al. Poisoning by substances of abuse in Morocco: Moroccan poison control center data (1980 to 2009) and risks factors for death. Rev Res J. 2014;3:1–8.

References

  • Birnbaum HG, White AG, Schiller M, et al. Societal costs of prescription opioid abuse, dependence, and misuse in the USA. Pain Med. 2011;12:657–667.
  • Amie Shei A, Hirst M, Kirson NY, et al. Estimating the healthcare burden of prescription opioid abuse in five European countries. Clinicoecon Outcomes Res. 2015;7:477–488.

References

  • Roncero C, Egido A, Rodríguez-Cintas L, et al. Substance use among medical students: a Literature Review 1988–2013. Actas Esp Psiquiatr. 2015;43:109–121.
  • Višnjić A, Jović S, Grbeša G. Alcohol consumption among students– a cross-sectional study at three largest universities in Serbia. Srp Arh Celok Lek. 2015;143:301–308.
  • Voigt K, Twork S, Mittag D, et al. Consumption of alcohol, cigarettes and illegal substances among physicians and medical students in Brandenburg and Saxony (Germany). BMC Health Serv Res. 2009;9:219.

References

  • Schep LJ, Knudsen K, Slaughter RJ, et al. The clinical toxicology of gamma-hydroxybutyrate, gamma-butyrolactone and 1,4-butanediol. Clin Toxicol (Phila). 2012;50:458–470.
  • Roberts DM, Smith MW, Gopalakrishnan M, et al. Extreme gamma-butyrolactone overdose with severe metabolic acidosis requiring hemodialysis. Ann Emerg Med. 2011;58:83–85.
  • Connors NJ, Hoffman RS, Nelson LS. Increased serum osmolality and metabolic acidosis following massive gamma-hydroxybutyrate consumption. Clin Toxicol (Phila). 2013;51:367.
  • Elian AA. A novel method for GHB detection in urine and its application in drug-facilitated sexual assaults. Forensic Sci Int. 2000;109:183–187.

References

References

  • Angelov D, O'Brien J, Kavanagh P. The syntheses of 1-(2-thienyl)-2-(methylamino) propane (methiopropamine) and its 3-thienyl isomer for use as reference standards. Drug Test Anal. 2013;5:145–149.
  • Welsh Emerging Drugs and Identification of Novel Substances Project (WEDINOS); [cited 2015 Nov 2]. Available at: http://www.wedinos.org/
  • Lee HM, Wood DM, Hudson S, et al. Acute toxicity associated with analytically confirmed recreational use of methiopropamine (1-(thiophen-2-yl)-2-methylaminopropane). J Med Toxicol. 2014; 10:299–302.

Reference

  • Lurie Y, Gopher A, Lavon O, et al. Severe paramethoxymethamphetamine (PMMA) and paramethoxyamphetamine (PMA) outbreak in Israel. Clin Toxicol (Phila). 2012;50:39–43.

References

References

  • Gassaway MM, Rives ML, Kruegel AC, et al. The atypical antidepressant and neurorestorative agent tianeptine is a mu-opioid receptor agonist. Transl Psychiatry. 2014; 4:e411.
  • Vadachkoria D, Gabunia L, Gambashidze K, et al. Addictive potential of tianeptine – the threatening reality. Georgian Med News. 2009;174:92–94.

References

  • Balali-Mood M, Proudfoot A, Critchley J, et al. Mefenamic acid overdosage. Lancet. 1981;1:1354–1356.
  • Baum C, Kennedy D, Forbes M. Utilization of nonsteroidal antiinflammatory drugs. Arthritis Rheum. 1985;28:686–692.
  • Marjoribanks J, Proctor M, Farquhar C, et al. Nonsteroidal anti‐inflammatory drugs for dysmenorrhoea. Cochrane Database Syst Rev. 2010;CD001751.
  • Lethaby A, Duckitt K, Farquhar C. Non‐steroidal anti‐inflammatory drugs for heavy menstrual bleeding. Cochrane Database Syst Rev. 2013;CD000400.
  • Hawton K, Saunders K, O'Connor R. Self-harm and suicide in adolescents. Lancet 2012;379:2373–2382.

References

  • Mowry JB, Spyker DA, Cantilena LR, et al. 2013 Annual Report of the American Association of Poison Control Centers’ National Poison Data System (NPDS): 31st Annual Report. Clin Toxicol (Phila). 2014;52:1032–1283.
  • Labadie M, Penouil F, Capaldo L. Rapport d’Activité et de Toxicovigilance. Centre antipoison et de toxicovigilance d’Aquitaine et de Poitou-Charentes; 2014.

Reference

Reference

  • Rhalem N, Chaoui H, Semlali I, et al. Exhaustivité des données de toxicovigilance au Maroc. Implication des services de santé publique et de surveillance épidémiologique. Toxicologie Maroc. 2012;15:8–15.

References

References

  • Tsonis L, Hantsch-Bardsley C, Gamelli RL. Hydrofluoric acid inhalation injury. J Burn Care Res. 2008;29:852–855.
  • Baxter A, Thain S, Banerjee A, et al. Targeted omics analyses, and metabolic enzyme activity assays demonstrate maintenance of key mucociliary characteristics in long term cultures of reconstituted human airway epithelia. Toxicol In Vitro. 2015;29:864–875.

References

  • Jurič DM, Finderle Ž, Šuput D, et al. The effectiveness of oxygen therapy in CO poisoning is pressure- and time-dependent. ToxicolLett. 2015;233:16–23.

References

  • Isbister GK, Friberg LE, Hackett LP, et al. Pharmacokinetics of quetiapine in overdose and the effect of activated charcoal. Clin Pharmacol Ther. 2007;81:821–827.
  • Grimm SW, Richtand NM, Winter HR, et al. Effects of cytochrome P450 3A modulators ketoconazole and carbamazepine on quetiapine pharmacokinetics. Br J Clin Pharmacol. 2006;61:58–69.

References

  • Exon JH. A review of the toxicology of acrylamide. J Toxicol Environ Health B Crit Rev. 2006;9:397–412.
  • Pennisi M, Malaguarnera G, Puglisi V, et al. Neurotoxicity of acrylamide in exposed workers. Int J Environ Res Public Health. 2013;10:3843–3854.

References

References

  • Woodward KN. Adverse reactions in humans to veterinary medicinal products. J Vet Pharmacol Ther. 2005;28:185–201.
  • Couzens G, Burke D. Veterinary high pressure injection injuries with inoculation for larger animals. J Hand Surg Br. 1995;4:497–499.

Reference

  • Dell'Aglio DM, Sutter ME, Schwartz MD, et al. Acute chloroform ingestion successfully treated with intravenously administered N-acetylcysteine. J Med Toxicol. 2010;6:143–146.

Reference

References

  • Park JS, Seok SJ, Gil HW, et al. Clinical outcome of acute intoxication due to ingestion of auxin-like herbicides. Clin Toxicol (Phila). 2011;49:815–819.
  • Kyong YY, Lee KU, Choi KH. Severe systemic intoxication following triclopyr-TEA ingestion. Clin Toxicol (Phila). 2010;48:942–944.
  • Carmichael NG, Nolan RJ, Perkins JM, et al. Oral and dermal pharmacokinetics of triclopyr in human volunteers. Hum Toxicol. 1989; 8:431–437.

Reference

Reference

References

  • Bateman DN, Dear JW, Thanacoody HKR, et al. Reduction of adverse effects from intravenous acetylcysteine treatment for paracetamol poisoning: a randomized controlled trial. Lancet. 2014;383:697–704.
  • Brown M, Bjorksten A, Medved I, et al. Pharmacokinetics of intravenous N-acetylcysteine in men at rest and during exercise. Eur J Clin Pharmacol. 2004;60:717–723.

Reference

  • Herrington L, Miller JL, Geller RJ, et al. Pediatric ingestion of citalopram: What is a safe dose for home management? Clin Toxicol (Phila). 2015;53:723–724.

Reference

  • Kreplick LW. Toxicity, salicylate. eMedicine J. 2001;2:6.

Reference

  • Rama BR. Intrathecal administration of xenobiotic. In: Hoffman RS, Howland MA, Lewin NA, et al, eds. Goldfrank’s Toxicologic Emergencies. 10th ed. New York, USA: McGraw-Hill Education, 2015:703–710.

Reference

References

  • Eap CB, Crettol S, Rougier JS, et al. Stereoselective block of hERG channel by (S)-methadone and QT interval prolongation in CYP2B6 slow metabolizers. Clin Pharmacol Ther. 2007;81:719–728.
  • Ansermot N, Albayrak O, Schläpfer J, et al. Substitution of (R,S)-methadone by (R)-methadone: impact on QTc interval. Arch Intern Med. 2010;170:529–536.

References

  • Flory JH, Wiesenthal AC, Thaler HT, et al. Methadone use and the risk of hypoglycemia for inpatients with cancer pain. J Pain Symptom Manage. 2015;51:79–87.
  • Gjedsted J, Dall R. Severe hypoglycemia during methadone escalation in an 8-year-old child. Acta Anaesthesiol Scand. 2015;59:1394–1396.
  • Fournier J-P, Azoulay L, Yin H, et al. Tramadol use and the risk of hospitalization for hypoglycemia in patients with noncancer pain. JAMA Intern Med. 2015;175:186–193.

Reference

  • Chiew AL, Fountain JS, Graudins A, et al. Summary Statement: New guidelines for management paracetamol poisoning in Australia and New Zealand. Med J Aust. 2015;203:215–218.

References

  • Bateman DN, Dear JW, Thanacoody HK, et al. Reduction of adverse effects from intravenous acetylcysteine treatment for paracetamol poisoning: a randomised controlled trial. Lancet. 2014;383:697–704.
  • Ferner RE, Langford NJ, Anton C, et al. Random and systematic medication errors in routine clinical practice: a multicenter study of infusions, using acetylcysteine as an example. Br J Clin Pharmacol. 2001;52:573–577.
  • Hayes BD, Klein-Schwartz W, Doyon S. Frequency of medication errors with intravenous acetylcysteine for acetaminophen overdose. Ann Pharmacother. 2008;42:766–770.

References

  • Hannemann F, Hartmann A, Schmitt J, et al. European multidisciplinary consensus statement on the use and monitoring of metal-on-metal bearings for total hip replacement and hip resurfacing. Orthop Traumatol Surg Res. 2013;99:263–271.
  • Bradberry SM, Wilkinson JM, Ferner RE. Systemic toxicity related to metal hip prostheses. Clin Toxicol (Phila). 2014;52:837–847.
  • Llobet JM, Domingo JL, Corbella J. Comparative effects of repeated parenteral administration of several chelators on the distribution and excretion of cobalt. Res Commun Chem Pathol Pharmacol. 1988;60:225–233.

References

  • Malekinejad M, Vazirian M. Transition to injection amongst opioid users in Iran: Implications for harm reduction. Int J Drug Policy. 2012; 23:333–337.
  • Salehi H, Sayadi AR, Tashakori M, et al. Comparison of serum lead level in oral opium addicts with healthy control group. Arch Iran Med. 2009;12:555–558.
  • Farzin L, Amiri M, Shams H, et al. Blood levels of lead, cadmium, and mercury in residents of Tehran. Biol Trace Elem Res. 2008;123:14–26.
  • Hayatbakhsh-Abbasi M, Ansari M, Shahesmaeili A, et al. Lead serum levels in opium-dependent individuals. Addict Health. 2009;1:106–109.
  • Domeneh BH, Tavakoli N, Jafari N. Blood lead level in opium dependents and its association with anemia: A cross-sectional study from the capital of Iran. J Res Med Sci. 2014;19:939–943.

References

  • Manini AF, Nelson LS, Stimmel B, et al. Incidence of adverse cardiovascular events in adults following drug overdose. Acad Emerg Med. 2012;19:843–849.
  • Manini AF, Hoffman RS, Stimmel B, et al. Clinical risk factors for in-hospital adverse cardiovascular events after acute drug overdose. Acad Emerg Med. 2015;22:499–507.

Reference

  • Weinbroum AA, Flaishon R, Sorkine P, et al. A risk-benefit assessment of flumazenil in the management of benzodiazepine overdose. Drug Saf. 1997;17:181–196.

References

Reference

  • Schlatter-Lanz I, Schneider L. [Vergiftungen mit opioidhaltigen Hustenmitteln]. Schweiz Apotheker Zeitung. 1989;127:645–648.

Reference

References

  • Dueñas A, Felipe S, Ruiz-Mambrilla M, et al. CO poisoning caused by inhalation of CH3Cl contained in personal defense spray. Am J Emerg Med. 2000;18:120–121.
  • Breakell A, Bodwala GG. CS gas exposure in a crowded night club: The consequences for an accident and emergency department. J Accid Emerg Med. 1988;15:56–57.

References

  • Shadnia S, Moghaddam HH. Fatal Intoxication with imidacloprid insecticide. Am J Emerg Med. 2008;26:634.
  • Mohamed F, Gawarammana I, Robertson TA, et al. Acute human self poisoning with imidacloprid compound: a neonicotinoid insecticide. PLoS One. 4:e5127.

Reference

  • Stoupel N, Monseu G, Cnockaerts P. [Human intoxication by chloralose. Clinical study and electroencephalography.] [Article in French] Acta Neurol Belg. 1970;70:352–358.

References

  • McTavish D, Goa K. Midodrine: a review of its pharmacologic properties and therapeutic use in orthostatic hypotension and secondary hypotensive disorders. Drugs. 1989; 38:757–777.
  • Perazella M. Efficacy and safety of midodrine in the treatment of dialysis-associated hypotension. Expert Opin Drug Saf. 2003;2:37–47.

References

  • Ostapowicz GA, Fontana RJ, Schiodt FV, et al. Results of a prospective study of acute liver failure at 17 tertiary care centers in the USA. Ann Intern Med. 2002;137:945–954.
  • Department of Health and Human Services, Food and Drug Administration. Organ-specific warnings: internal analgesic, antipyretic, and antirheumatic drug products for over-the-counter human use; final monograph. Federal Register. 2009;74:19385–19409.

References

  • Mijatović V, Samojlik I, Ajduković N, et al. Methadone-related deaths – epidemiological, pathohistological, and toxicological traits in 10-year retrospective study in Vojvodina, Serbia. J Forensic Sci. 2014;59:1280–1285.
  • Mijatović V, Dickov A, Petković S, et al. Safety assessment of low doses of methadone in combination with benzodiazepines in real occasions during methadone maintenance treatment. Heroin Addict Relat Clin Probl. 2013;15:29–34.
  • Mijatović V, Samojlik I, Petković S, et al. Consequences of cardiac toxicity in patients on low methadone doses during methadone maintenance treatment. Heroin Addict Relat Clin Probl. 2015;17:73–78.

References

References

Reference

  • Boom S, Talluri K, Janssens L, et al. Single and multiple-dose pharmacokinetics and dose proportionality of the psychotropic agent paliperidone extended release. J Clin Pharmacol. 2009;49:1318–1330.

Reference

References

  • Hendrikx JJ, Rosing H, Schinkel AH, et al. Combined quantification of paclitaxel, docetaxel and ritonavir in human feces and urine using LC-MS/MS. Biomed Chromatogr. 2014;28:302–310.
  • Polasek TM, Elliot DJ, Lewis BC, et al. Mechanism-based inactivation of human cytochrome P4502C8 by drugs in vitro. J Pharmacol Exp Ther. 2004;311:996–1007.

References

  • American College of Medical Toxicology: ACMT position statement: interim guidance for the use of lipid resuscitation therapy. J Med Toxicol. 2011;7:81–82.
  • Moussot PE, Marhar F, Minville V, et al. Use of intravenous lipid 20% emulsion for the treatment of a voluntary intoxication of flecainide with refractory shock. Clin Toxicol (Phila). 2011;49:514.
  • Sivalingam SK, Gadiraju VT, Hariharan MV, et al. Flecainide toxicity – treatment with intravenous fat emulsion and extra corporeal life support. Acute Card Care. 2013;15:90–92.

Reference

  • Altyar A, Kordi L, Skrepnek G. Clinical and economic characteristics of emergency department visits due to acetaminophen toxicity in the USA. BMJ Open. 2015;5:e007368.

Reference

  • Vogiazi MG, Jacobsen-Dickman E, Deboer MD, et al. Vitamin D supplementation and risk of toxicity in pediatrics: a review of current literature. J Clin Endocrinol Metab. 2014;99:1132–1141.

References

References

Reference

  • Pongudom S, Chinthammitr Y. Inadvertent intrathecal vincristine administration: report of a fatal case despite cerebrospinal fluid lavage and a review of the literature. J Med Assoc Thai. 2011;94:S258–S263.

References

  • Marraffa JM, Nacca NE, Stork CM, et al. Phenibut: One poison center’s experience. Clin Toxicol (Phila). 2014;52:736–737.
  • Wong A, Little M, Caldicott D, et al. Analytically confirmed recreational use of phenibut (β-phenyl-γ-aminobutyric acid) bought over the Internet. Clin Toxicol (Phila). 2015;53:783–784.
  • Downes MA, Berling IL, Mostafa A, et al. Acute behavioural disturbance associated with phenibut purchased via an Internet supplier. Clin Toxicol (Phila). 2015;53:636–638.

Reference

  • Rama BR. Intrathecal administration of xenobiotic. In: Hoffman RS, Howland MA, Lewin NA, et al, eds. Goldfrank’s Toxicologic Emergencies. 10th ed. New York, USA: McGraw-Hill Education, 2015:703–10.

Reference

  • Personne M, Sjöberg G, Persson H. Citalopram overdose—review of cases treated in Swedish hospitals. J Toxicol Clin Toxicol. 1997;35:237–240.

Reference

  • Jiménez-Jiménez FJ, Alonso-Navarro H, Fernández-Diaz A, et al. [Neurotoxic effects induced by the topical administration of cycloplegics. A case report and review of the literature.] [Article in Spanish] Rev Neurol. 2006;43:603–609.

References

  • Böger RH, Schmidt G. Analgetika. In: Schwabe U, Paffrath D, eds. Arzneiverordnungsreport 2014. Springer-Verlag Berlin-Heidelberg, Germany; 2014:301–319.
  • Ryan NM, Isbister GK. Tramadol overdose causes seizures and respiratory depression but serotonin toxicity appears unlikely. Clin Toxicol (Phila). 2015;53:545–550.

References

Reference

Reference

References

  • Balme K, Roberts JC, Glasstone M, et al. The changing trends of childhood poisoning at a tertiary children’s hospital in South Africa. S Afr Med J. 2012;102:142–146.
  • Veale DJH, Wium CA, Müller GJ. Toxicovigilance I: a survey of acute poisonings in South Africa based on Tygerberg Poison Information Centre data. S Afr Med J. 2013;103:293–297.

Reference

References

  • Guidelines for the evaluation of sexual abuse of children: subject review. American Academy of Pediatrics Committee on Child Abuse and Neglect. Pediatrics. 1999;103:186–191.
  • Yin S. Malicious use of nonpharmaceuticals in children. Child Abuse Negl. 2011;35:924–929.
  • Calello DP, Henretig FM. Pediatric toxicology: specialized approach to the poisoned child. Emerg Med Clin North Am. 2014;32:29–52.

References

  • World Health Organisation. Poisoning prevention and management 2011; [cited 2015 Nov 15]. Available at: www.who.int/pcs/poisons/en
  • Watson AW, Litovitz T, Belson MG, et al. The Toxic Exposure Surveillance System (TESS): risk assessment and real-time toxicovigilance across USA poison centers. Toxicol Appl Pharmacol. 2005;207:604–610.
  • Muñoz R, Borobia A, Qunitana M, et al. Desarrollo y validación de un programa de toxicovigilancia con detección automatizada de casos en un hospital terciario (SAT-HULP). Emergencias. 2013;25:423–429.
  • Yang CM, Reinke W. Feasibility and validity of International Classification of Diseases based case-mix indices. BMC Health Serv Res. 2006;6:125.

References

Reference

References

References

  • Grundlingh J, Dargan P, El-Zanfaly M, et al. 2,4-Dinitrophenol (DNP): a weight loss agent with significant acute toxicity and risk of death. J Med Toxicol. 2011;7:205–212.
  • Kamour A, George N, Gwynnette D, et al. Increasing frequency of severe clinical toxicity after use of 2,4-dinitrophenol in the UK. A report from the National Poisons Information Service. Emerg Med J.2015;32:383–386.

Reference

Reference

  • Gudjonsdottir GA, Thordardottir AM, Kristinsson J. Acute poisonings in Iceland: A prospective study on poisonings presenting to the Emergency Department at Landspitali University Hospital. Clin Toxicol (Phila). 2014;52:312.

References

  • Hughes K, McHale P, Wyke S, et al. Child injury: using national emergency department monitoring systems to identify temporal and demographic risk factors. Inj Prev. 2014;20:74–80.
  • Chien C, Marriott JL, Ashby K, et al. Unintentional ingestion of over the counter medications in children less than 5 years old. J Paediatr Child Health. 2003;39:264–269.

Reference

References

  • Sanchis-Gomar F, Pareja-Galeano H, Cervellin G, et al. Energy drink overconsumption in adolescents: implications for arrhythmias and other cardiovascular events. Can J Cardiol. 2015;31:572–575.
  • O'Brien MC, McCoy TP, Rhodes SD, et al. Caffeinated cocktails: energy drink consumption, high-risk drinking, and alcohol-relatedconsequences among college students. Acad Emerg. 2008;15:453–460.

References

  • Levêque D, Jehl F. Molecular pharmacokinetics of Catharanthus (vinca) alkaloids. J Clin Pharmacol. 2007;47:579–588.
  • Choi HJ, Cho BC, Shin SJ, et al. Combination of topotecan and etoposide as a salvage treatment for patients with recurrent small cell lung cancer following irinotecan and platinum first-line chemotherapy. Cancer Chemother Pharmacol. 2008;61:309–313.
  • Limem-Ben Amor I, Boubaker J, Ben Sgaier M, et al. Phytochemistry and biological activities of Phlomis species. J Ethnopharmacol 2009;125:183–202.
  • Kamel MS, Mohamed KM, Hassanean HA, et al. Iridoid and megastigmane glycosides from Phlomis aurea. Phytochemistry 2000; 55:353–357.
  • Sarkhail P, Amin G, Shafiee A. Composition of the essential oil of Phlomis olivieri Benth from north of Iran. Daru J Pharm Sci 2006; 14:71–74.

References

  • The Danish Ministry of Health and Prevention. Register of medicinal product statistics; [cited 2015 Nov 20]. Available at: www.medstat.dk/
  • Fuhrmann M, Hruby K, Lenz K, et al. [New aspects of chlorprothixen-poisoning.] [Article in German] Wien Klin Wochenschr. 1982;94:150–153.

Reference

  • James LP, Capparelli EV, Simpson PM, et al. Acetaminophen-associated hepatic injury: evaluation acetaminophen-protein adducts in children and adolescents with acetaminophen overdose. Clin Pharmacol Ther. 2008;84:684–690.

References

  • Antolino-Lobo I, Meulenbelt J, van den Berg M, et al. A mechanistic insight into 3,4-methylenedioxymethamphetamine ("ecstasy")-mediated hepatotoxicity. Vet Q. 2011;31:193–205.
  • Dias da Silva D, Carmo H, Lynch A, et al. An insight into the hepatocellular death induced by amphetamines, individually and in combination: the involvement of necrosis and apoptosis. Arch Toxicol. 2013;87:2165–2185.

References

  • Rickli A, Luethi D, Reinisch J, et al. Receptor interaction profiles of novel N-2-methoxybenzyl (NBOMe) derivatives of 2,5-dimethoxy-substituted phenethylamines (2C drugs). Neuropharmacology. 2015;99:546–553.
  • Simmler LD, Buser T, Donzelli M, et al. Pharmacological characterization of designer cathinones in vitro. Br J Pharmacol. 2013;168:458–470.

References

  • Gosselin D, Juurlink DN, Kielstein JT, et al. Extracorporeal treatment for acetaminophen poisoning: recommendations from the EXTRIP workgroup. Clin Toxicol (Phila). 2014;52:856–867.
  • Mitzner S. Extracorporeal liver support-albumin dialysis with molecular adsorbent recirculating system. Ann Hepatol. 2011;10:S21–S28.

Reference

  • George T, Shaikh AI, Thomas L, et al. Severe methemoglobinemia due to insecticide poisoning. Indian J Crit Care Med. 2014;18:113–114.

Reference

  • Saviuc P, Danel V. New syndromes in mushroom poisoning. Toxicol Rev. 2006;25:199–209.

References

  • Pinillos MA, Gómez J, Elizalde J, et al. [Poisoning by foodstuffs, plants and mushrooms.] [Article in Spanish] An Sist Sanit Navar. 2003;26:243–263.
  • Díaz JH. Evolving global epidemiology, syndromic classification, general management, and prevention of unknown mushroom poisonings. Crit Care Med. 2005;33:419–426.
  • Benítez Macías JF, García Gil D, Brun Romero FM, et al. [Acute mushrooms poisoning.] [Article in Spanish] Rev Clín Esp. 2009;209:542–549.

References

  • García Piney E, Fonseca Aizpuru EM, Nuño Mateo FJ. Mordedura de víbora grado II [Grade II snake bites]. Medicina Clinica. 2005;125:240.
  • Gold BS, Dart RC, Barish RA. Bites of venomous snakes. N Engl J Med. 2002;347:347–356.
  • Erce R, Arraiza JM. Estudio sobre incidencia de emponzoñamiento por ofidios en la Comunidad Navarra [Study on the incidence of envenomation by snakes in the Navarra Community]. Comunicación a las IV Jornadas de AP de Navarra, Pamplona. November 1992.

Reference

  • Bateman DN, Dear JW, Thanacoody HK, et al. Reduction of adverse effects from intravenous acetylcysteine treatment for paracetamol poisoning: a randomised controlled trial. Lancet. 2014;383:697–704.

Reference

  • Chan BS, O’Leary M, Isbister G, et al. The use of digoxin-specific antibodies in chronic digoxin poisoning. Clin Toxicol (Phila). 2015;53:241.

References

  • Greene SL, Gawarammana I, Wood DM, et al. Relative safety of hyperinsulinaemia/euglycaemia therapy in the management of calcium channel blocker overdose: a prospective observational study. Intensive Care Med. 2007;33:2019–2024.
  • Engebretsen KM, Kaczmarek KM, Morgan J, et al. High-dose insulin therapy in beta-blocker and calcium channel-blocker poisoning. Clin Toxicol (Phila). 2011;49:277–283.

Reference

  • Schaumann W, Kaufmann B, Neubert P, Smolarz A. Kinetics of the Fab fragments of digoxin antibodies and of bound digoxin in patients with severe digoxin intoxication. Eur J Clin Pharmacol. 1986;30:527–533.

Reference

References

  • Mellanby E. Alcohol: its absorption into and disappearance from blood under different conditions. Gt Brit Medical Research Council, Special Report Series 1919; No. 31.
  • Marczinski CA, Fillmore MT. Acute alcohol tolerance on subjective intoxication and simulated driving performance in binge drinkers. Psychol Addict Behav. 2009;23:238–247.
  • Weafer J, Fillmore MT. Acute tolerance to alcohol impairment of behavioral and cognitive mechanisms related to driving: drinking and driving on the descending limb. Psychopharmacology (Berl) 2012;220:697–706.

Reference

  • Valiveti S, Kiptoo PK, Hammell DC, et al. Transdermal permeation of WIN 55,212-2 and CP 55,940 in human skin in vitro. Int J Pharm. 2004;278:173–180.

References

  • Gauthier S, Grass H, Lory M, et al. Lethal carbon monoxide poisoning in wood pellet storerooms - two cases and a review of the literature. Ann Occup Hyg. 2012;56:755–763.
  • Svedberg UR, Högberg HE, Högberg J, et al. Emission of hexanal and carbon monoxide from storage of wood pellets, a potential occupational and domestic health hazard. Ann Occup Hyg. 2004;48:339–349.
  • Kuang X, Shankar TJ, Sokhansanj S, et al. Effects of headspace and oxygen level on off-gas emissions from wood pellets in storage. Ann Occup Hyg. 2009;53:807–13.

Reference

  • Belton P, Sharngoe T, Maguire FM, et al. Cardiac infection and sepsis in 3 intravenous bath salts drug users. Clin Infect Dis. 2013;56:e102–e104.

References

  • Sanchez-Verlaan P, Geeraerts T, Buys S, et al. An unusual cause of severe lactic acidosis. Cyanide poisoning after bitter almond ingestion. Intensive Care Med. 2011;37:168–169.
  • Shragg TA, Albertson TE, Fisher CJ Jr. Cyanide poisoning after bitter almond ingestion. West J Med. 1982;136:65–69.
  • Nader R, Mathieu-Daudé JC, Devaux M, et al. Child cyanide poisoning after ingestion of bitter almonds. Clin Toxicol (Phila). 2010;48:574–575.
  • Toomey V, Nickum E, Flurer C. Cyanide and amygdalin as indicators of the presence of bitter almonds in imported raw almonds. JForensic Sci. 2012;57:1313–1317.

References

  • Grundlingh J, Dargan PI, El-Zanfaly M, et al. 2,4-dinitrophenol (DNP): a weight loss agent with significant acute toxicity and risk of death. J Med Toxicol. 2011;7:205–212.
  • Kamour A, George N, Gwynnette D, et al. Increasing frequency of severe clinical toxicity after use of 2,4-dinitrophenol in the UK: a report from the National Poisons Information Service. Emerg MedJ. 2015;32:383–386.
  • Bartlett J, Brunner M, Gough K. Deliberate poisoning with dinitrophenol (DNP): an unlicensed weight loss pill. Emerg Med J. 2010;27:159–160.

References

Reference

  • Van de Velde M, Wouters PF, Rolf N, et al. Long-chain triglycerides improve recovery from myocardial stunning in conscious dogs. Cardiovascular Res. 1996;32:1008–1015.

Reference

  • Sohn CH, Seo DW, Ryoo SM, et al. Life-threatening methemoglobinemia after unintentional ingestion of antifreeze admixtures containing sodium nitrite in the construction sites. Clin Toxicol. 2014;52:44–47.

References

  • Ginsburg B. Vitamins. In: Nelson LS, Levin NA, Howland MA, et al., eds. Goldfrank’s Toxicologic Emergencies. 9th ed. New York, USA: Mc-Graw Hill Medical; 2011:609–623.
  • Ulmeanu C. Vitamin Poisoning. In: Acute Poisoning in children and adolescents. Tridona Olteniţa 2015;219–220.

Reference

  • Gummin DG. Hydrocarbons. In: Nelson LS, Levin NA, Howland MA, et al., eds. Goldfrank’s Toxicologic Emergencies. 9th ed. New York, USA: Mc-Graw Hill Medical; 2011:1386–1399.

Reference

  • Wong A, Sivilotti ML, Dargan PI, et al. External validation of a paracetamol-aminotransferase multiplication product used to predict hepatotoxicity in paracetamol overdose. Clin Toxicol (Phila). 2015;53:807–814.

Reference

  • Wong A, Sivilotti ML, Dargan PI, et al. External validation of a paracetamol-aminotransferase multiplication product used to predict hepatotoxicity in paracetamol overdose. Clin Toxicol (Phila). 2015;53:807–814.

Reference

References

  • Bateman DN, Dear JW, Thanacoody HKR, et al. Reduction of adverse effects from intravenous acetylcysteine treatment for paracetamol poisoning: a randomized controlled trial. Lancet. 2014;383:697–704.
  • Bateman DN, Dear JW, Thanacoody HKR, et al. Treatment of paracetamol overdose - authors' reply. Lancet. 2014;383:1383.
  • Ben-Shachar R, Chen Y, Luo S, et al. The biochemistry of acetaminophen hepatotoxicity and rescue: a mathematical model. Theor Biol Med Model. 2012:9:55.

Reference

  • Fausch F, Uehlinger DE, Jakob S, et al. Haemodialysis in massive caffeine intoxication. Clin Kidney J. 2012;5:150–152.

References

References

  • Agarwal A, Lemos N. Significance of bile analysis in drug-induced deaths. J Anal Toxicol. 1996;20:61–63.
  • Leikin JB, Watson WA. Post-mortem toxicology: what the dead can and cannot tell us. J Toxicol Clin Toxicol. 2003;4:47–56.
  • Bévalot F, Cartiser N, Bottinelli C, et al. Correlation of bile and vitreous humor concentrations with blood drug concentrations for forensic interpretation: a comparative study between animal experimental and human postmortem data. Forensic Toxicol. 2015;33:131–140.
  • Vanbinst R, Koenig J, Di Fazio V, et al. Bile analysis of drugs in postmortem cases. Forensic Sci Int. 2002;128:35–40.

Reference

  • Uchiyama N, Matsuda S, Kawamura M, et al. Two new-type cannabimimetic quinolinyl carboxylates, QUPIC and QUCHIC, two new cannabimimetic carboxamide derivatives, ADB-FUBINACA and ADBICA, and five synthetic cannabinoids detected with a thiophene derivative α-PVT and an opioid receptor agonist AH-7921 identified in illegal products. Forensic Toxicol. 2013;31:223–240.

Reference

  • Schep LJ, Schmierer DM, Fountain JS. Veratrum poisoning. Toxicol Rev. 2006;25:73–78.

Reference

  • Burns MJ, Linden CH, Graudins A, et al. A comparison of physostigmine and benzodiazepines for the treatment of anticholinergic poisoning. Ann Emerg Med. 2000;35:374–381.

Reference

Reference

  • Kanokmedhakul S, Kanokmedhakul K, Prajuabsuk T, et al. A bioactive triterpenoid and vulpinic acid derivatives from the mushroom Scleroderma citrinum. Planta Med. 2003;69:568–571.

Reference

References

  • Chan TY. Aconite poisoning. Clin Toxicol (Phila). 2009;47:279–285.
  • Gottignies P, El Hor T, Tameze JK, et al. Successful treatment of monkshood (aconite napel) poisoning with magnesium sulfate. Am J Emerg Med. 2009; 27:755.e1–4.

References

  • Wilson CR, Sauer JM, Hooser SB. Taxines: a review of the mechanism and toxicity of yew (Taxus spp.) alkaloids. Toxicon. 2001;39:175–185.
  • Willaert W, Claessens P, Vankelecom B, et al. Intoxication with Taxus baccata: cardiac arrhythmias following yew leaves ingestion. Pacing Clin Electrophysiol. 2002;25:511–512.

References

  • Worbs S, Köhler K, Pauly D, et al. Ricinus communis intoxications in human and veterinary medicine – a summary of real cases. Toxins (Basel). 2011;3:1332–1372.
  • Røen BT, Opstad AM, Haavind A, et al. Serial ricinine levels in serum and urine after ricin intoxication. J Anal Toxicol. 2013;37:313–317.
  • Hamelin EI, Johnson RC, Osterloh JD, et al. Evaluation of ricinine, a ricin biomarker, from a non-lethal castor bean ingestion. J Anal Toxicol. 2012;36:660–662.

References

References

  • German Jørgensen JR, Andersen AE. [Fatal exposure to Aconitum napellus.] [Article in Danish] Ugeskr Laeger. 2013;175:1707–1708.
  • Plants – Aconitum. POISINDEX® System (electronic version). Truven health analytics, Greenwood Village, Colorado, USA; [cited 2015 Nov 21]. Available at: http://www.micromedexsolutions.com/

References

  • O'Leary MA, Kornhauser RS, Hodgson WC, et al. An examination of the activity of expired and mistreated commercial Australian antivenoms. Trans R Soc Trop Med Hyg. 2009; 103:937–942.
  • Rentmeester L, Burton D, Fitzgerald R, et al. Immunoglobulin concentration & venom binding activity of expired snake antivenoms. Clin Toxicol (Phila) 2014;52:695.
  • Mannel R, Pudovka Gross OA, Gross GA. Coral snake antivenin's deadly deadline. Toxicon. 2012;60:225.

References

  • Soulaymani Bencheikh R, Faraj Z, Semlali I, et al. [National strategy in the battle against scorpion stings and envenomations. Application and evaluation.] [Article in French] Bull Soc Pathol Exot. 2003;96:317–319.
  • Soulaymani-Bencheikh R, Semlali I, Ghani A, et al. Implantation et analyse d’un registre des piqûres de scorpion au Maroc. Santé Publique. 2004;16:487–498.

Reference

References

  • Blaylock RS, Lichtman AR, Potgieter PD. Clinical manifestations of Cape cobra (Naja nivea) bites. A report of two cases. S Afr Med J. 1985;68:342–344.
  • Warrick BJ, Boyer LV, Seifert SA. Non-native (exotic) snake envenomations in the US, 2005–2011. Toxins (Basel). 2014;6:2899–911.
  • Schaper A, Desel H, Ebbecke M, et al. Bites and stings by exotic pets in Europe: an 11 year analysis of 404 cases from Northeastern Germany and Southeastern France. Clin Toxicol (Phila). 2009;47:39–43.

Reference

  • De Haro L, Prost N, Arditi J, et al. Efficacy of local temperature variation in the treatment of Mediterranean fish envenomations: experience of the Marseilles Poison Center during the summer of 1999. J Eur Urgences. 2001;14:171–173.

References

  • Sutherland SK, Tibballs J. Family Hydrophiidae, Sea Snakes. In: Sutherland SK, Tibballs J. Australian Animal Toxins. 2nd ed. Oxford, England: Oxford University Press; 2001:247–285.
  • Fulde GW, Smith F. Sea snake envenomation at Bondi. Med J Aust. 1983;141:44–45.

Reference

  • Boels D, Hamel JF, Bretaudeau Deguigne M, et al. European viper envenomings: Assessment of Viperfav™ and other symptomatic treatments. Clin Toxicol (Phila). 2012;50:189–196.

References

  • Birsa LM, Verity PG, Lee RF. Evaluation of the effects of various chemicals on discharge of and pain caused by jellyfish nematocysts. Comp Biochem Physiol C. 2010;151:426–430.
  • Isbister GK. Managing injuries by venomous sea creatures in Australia. Aust Prescr. 2007;30:117–121.

Reference

  • Chapman S, Pittman J, Johnson M, et al. Sodium hypochlorite bleach ingestion in two dogs. Vet Med. 2008;103:13–18.

Reference

  • Gwaltney-Brant S. Household and industrial products. In: Plumlee KH, ed. Clinical Veterinary Toxicology. St Louis, USA: Mosby; 2004:140–142.

Reference

  • Fiaccadori E, Maggiore U, Rotelli C, et al. Acute renal and hepatic failure due to accidental percutaneous absorption of 1,2-dichlorpropane contained in a commercial paint fixative. Nephrol Dial Transplant. 2003;18:219–220.

Reference

  • Gwaltney-Brant S. Chocolate intoxication. Vet Med. 2001;96:108–111.

References

  • McKenzie LB, Ahir N, Stolz U, et al. Household cleaning product-related injuries treated in US emergency departments in 1990–2006. Pediatrics. 2010;126:509–516.
  • Williams H, Jones S, Wood K, et al. Reported toxicity in 1486 liquid detergent capsule exposures to the UK National Poisons Information Service 2009–2012, including their ophthalmic and CNS effects. Clin Toxicol (Phila). 2014;52:136–140.
  • Schaper A, Renneberg B, Desel H, et al. Intoxication-related fatalities in northern Germany. Eur J Intern Med. 2006;17:474–478.
  • Read JL. Can fastidiousness kill the cat? The potential for target-specific poisoning of feral cats through oral grooming. Ecol Manag Restor. 2010;11:230–233.

Reference

  • Meurs KM, Breitschwerdt EB, Baty CJ, Young MA. Postsurgical mortality secondary to zinc toxicity in dogs. Vet Hum Toxicol. 1999;33:579–583.

Reference

  • Roels S, Coopman V, Vanhaelen P, et al. Lethal ricin intoxication in two adult dogs: toxicologic and histopathologic findings. J Vet Diagn Invest. 2010;22:466–468.

Reference

  • Mackenzie SD, Blois S, Hayes G, et al. Oral thermal injury associated with puncture of a salbutamol metered-dose inhaler in a dog. J Vet Emerg Crit Care (San Antonio). 2012;22:494–497.

Reference

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.